Tuesday, December 29, 2020 1:47:01 PM
“We specialize in providing biostatistics and programming support for the design, conduct, analysis, and reporting of clinical trials involving medical products.”
“To date, our principals have supported the approval or clearance of over 60 products inclusive of drugs, devices, in vitro diagnostics, biologics, and combination products.”
“located in Framingham Massachusetts but we provide support for an international clientele”
On Dr Lavin: “He has served as the Lead Biostatistician for 64 FDA approvals to date including 39 PMAs, 19 NDAs, 4 BLAs, and a de novo and HDE with more pending. These approvals have resulted in >$25B in increased client valuations.
He also advised FDA from 1983 through 2015 on product approvals and public policy matters as a Special Government Employee.”
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM